Viridian Therapeutics Inc... (VRDN)
NASDAQ: VRDN
· Real-Time Price · USD
18.53
0.09 (0.49%)
At close: Aug 15, 2025, 3:59 PM
18.50
-0.16%
After-hours: Aug 15, 2025, 07:26 PM EDT
Viridian Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 305K | 302K | 302K | 302K | 288K | 288K | 314K | 347K | 1.47M | 1.65M | 1.77M | 1.88M | 894K | 1.73M | 2.96M | 2.8M | 2.6M | 1.67M |
Cost of Revenue | n/a | 5.79M | 6.14M | 6.49M | 6.82M | 1.46M | 1.32M | 40.29M | 62.07M | 83.35M | 83.29M | 44.6M | 30.61M | 21.46M | 35.12M | 49.75M | 44.74M | 36.01M |
Gross Profit | 182K | -5.61M | -5.96M | -6.18M | -6.53M | -1.17M | -1.01M | -39.94M | -60.6M | -81.7M | -81.52M | -42.72M | -29.71M | -19.73M | -32.16M | -46.94M | -42.14M | -34.33M |
Operating Income | -371.58M | -337M | -299.04M | -283.04M | -250.79M | -237.87M | -254.45M | -232.04M | -210.6M | -180.89M | -134.3M | -114.32M | -98.67M | -87.1M | -79.73M | -141.25M | -132.52M | -120.9M |
Interest Income | 30.49M | 31.73M | 32.13M | 29.06M | 25.43M | 22.02M | 18.56M | 16.48M | 13.36M | 9.21M | 4.92M | 1.6M | 652K | 459K | 318K | 216K | 134K | 133K |
Pretax Income | -344.06M | -308.32M | -269.95M | -257.08M | -228.06M | -218.13M | -237.73M | -216.66M | -197.9M | -172.33M | -129.87M | -113.03M | -98.17M | -86.65M | -79.41M | -141.21M | -132.66M | -121.13M |
Net Income | -344.06M | -308.32M | -269.95M | -257.08M | -228.06M | -218.13M | -237.63M | -213.27M | -193.64M | -168.07M | -125.52M | -111.96M | -97.98M | -86.45M | -79.41M | -141.21M | -132.66M | -121.13M |
Selling & General & Admin | 67.31M | 63.16M | 61.08M | 78.49M | 85M | 88.19M | 95M | 71.86M | 59.81M | 48.65M | 35.18M | 32.23M | 29.59M | 28M | 25.8M | 24.44M | 20.52M | 16.7M |
Research & Development | 304.58M | 274.14M | 238.25M | 204.85M | 166.08M | 149.97M | 159.76M | 160.53M | 152.26M | 133.89M | 100.89M | 83.97M | 69.97M | 60.83M | 56.89M | 49.75M | 44.74M | 36.01M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -20.79M | -20.79M | -20.79M |
Operating Expenses | 371.89M | 337.31M | 299.34M | 283.34M | 251.07M | 238.16M | 254.76M | 232.38M | 212.07M | 182.54M | 136.08M | 116.2M | 99.56M | 88.83M | 82.69M | 74.19M | 65.25M | 52.71M |
Interest Expense | 2.96M | 3.04M | 3.05M | 3.1M | 2.7M | 2.27M | 1.85M | 1.1M | 663K | 651K | 486K | 321K | 157K | 3K | 3K | 180K | 273K | 367K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 371.89M | 337.31M | 299.34M | 283.34M | 251.07M | 238.16M | 254.76M | 232.38M | 212.07M | 182.54M | 136.08M | 116.2M | 99.56M | 88.83M | 82.69M | 74.19M | 65.25M | 52.71M |
Income Tax Expense | n/a | n/a | -145K | -145K | -280K | -280K | -240K | -3.52M | -4.27M | -4.04M | -4.13M | -846K | 125K | -93K | 158K | 285K | 146K | 170K |
Shares Outstanding (Basic) | 81.59M | 81.34M | 80.05M | 66.42M | 63.85M | 61.1M | 49.68M | 43.65M | 43.25M | 42.24M | 40.54M | 33.74M | 27.76M | 26.13M | 11.18M | 11.18M | 8.11M | 6.34M |
Shares Outstanding (Diluted) | 81.59M | 81.34M | 80.05M | 66.42M | 63.85M | 61.1M | 49.68M | 43.65M | 43.25M | 42.24M | 40.54M | 33.74M | 27.76M | 26.13M | 11.18M | 11.18M | 8.11M | 6.34M |
EPS (Basic) | -3.83 | -3.85 | -3.77 | -4.31 | -4.25 | -4.5 | -5.32 | -5.02 | -4.76 | -4.55 | -3.92 | -5.46 | -5.89 | -7.05 | -8.98 | -29.46 | -29.68 | -29.28 |
EPS (Diluted) | -3.83 | -3.85 | -3.77 | -4.31 | -4.25 | -4.5 | -5.32 | -5.02 | -4.76 | -4.55 | -3.92 | -5.46 | -5.89 | -7.05 | -8.98 | -29.46 | -29.68 | -29.28 |
EBITDA | -340.62M | -304.36M | -265.76M | -252.61M | -223.78M | -214.39M | -234.56M | -214.39M | -196.41M | -171.12M | -128.9M | -111.78M | -96.96M | -85.62M | -78.55M | -140.75M | -132.19M | -120.66M |
EBIT | -341.1M | -305.27M | -266.9M | -253.98M | -225.35M | -215.86M | -235.89M | -215.56M | -197.24M | -171.68M | -129.39M | -112.71M | -98.02M | -86.64M | -79.47M | -141.08M | -132.44M | -120.82M |
Depreciation & Amortization | 483K | 512K | 740K | 967K | 1.17M | 1.46M | 1.32M | 1.17M | 895K | 620K | 555K | 991K | 1.06M | 1.03M | 1.02M | 438K | 365K | 304K |